Biotech news (5 April 1999)
Glaxo Wellcome appears to have abandoned plans to merge with the US drugs giant Bristol Myers Squibb. Sources claim that informal meetings had taken place, but merger negotiations broke down at the end of last year and are unlikely to be resumed. However, it is thought that Glaxo is looking...
